Evidence map›Paper›PMID 28400708›Full record

ArticleCost effectiveness and resource allocation : C/E2017

Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan.

Ellen Rafferty, Mohsen Yaghoubi, Jeff Taylor, Marwa Farag

Abstract read
In one paragraph

Article in Cost effectiveness and resource allocation : C/E, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Self-care and minor ailments: The view from Canada.Exploratory research in clinical and social pharmacy · 2024
    Article
  7. Article
  8. Uptake of community pharmacist prescribing over a three-year period.Exploratory research in clinical and social pharmacy · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Minor ailments, major problems: a critical appraisal of Rafferty et al. (2017).Cost effectiveness and resource allocation : C/E · 2018
    Article
  17. Article
  18. Geographic distribution of Ontario pharmacists: A focus on rural and northern communities.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ellen Rafferty *School of Public Health, University of Saskatchewan, 104 Clinic Place, Room 3334, Saskatoon, SK S7N 5E3 Canada.
Mohsen Yaghoubi *School of Public Health, University of Saskatchewan, 104 Clinic Place, Room 3334, Saskatoon, SK S7N 5E3 Canada.
Jeff Taylor *College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.
Marwa Farag *School of Public Health, University of Saskatchewan, 104 Clinic Place, Room 3334, Saskatoon, SK S7N 5E3 Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealth care systems around the world have started to develop pharmacists prescribing for minor ailments (PPMA) programs. These programs aim to improve the efficiency of care, reduce physician visits, and increase the accessibility to prescription medication (Rx). This study performed an economic impact analysis of the pharmacists prescribing for minor ailments program in Saskatchewan.

methodsWe measured costs for the program and the alternative scenario (i.e. no PPMA program) from a public payer and societal perspective, using primary data on pharmacists prescribing consultations in Saskatchewan. Furthermore, we calculated public payer and societal savings, and return on investment ratios for the program, as well as projecting the costs and benefits over the next 5 years.

resultsOverall, we found that from a societal perspective, the Saskatchewan PPMA program saved the province approximately $546,832 in 2014, while according to the public payer perspective, the program was only marginally cost-saving in 2014. After 5 years of implementation, from a societal perspective, cumulative cost savings were projected to be $3,482,660, and the return on investment ratio was estimated to be 2.53.

conclusionsOur results demonstrate that this type of program may prove cost-saving and lead to improved access to the health care system in Canada, especially if savings to society are considered. This type of PPMA program may prove economically feasible and beneficial in many countries considering expanding pharmacists scope of practice.

Indexed as

Cost analysisCost savingsEconomic impactMinor ailmentsPharmacists prescribingROISocietal and public payer perspectives

Identifiers

PMID28400708
PMCPMC5387257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.